City

Clinical trials near Ann Arbor, United States

Active studies with a listed research site in Ann Arbor, United States.

20active studies

15recruiting now

1countries represented

71largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 4

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Psoriasis, Overweight or ObesityCondition

TirzepatideTreatment

United States39 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06857942See eligibility →

Recruiting nowPhase 2

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

B-cell Acute Lymphoblastic Leukemia, ObesityCondition

IDEAL2 InterventionTreatment

United States16 locations

Etan OrgelSponsor

Updated 2026-08-19 · NCT05082519See eligibility →

Recruiting nowPhase 3

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

Alcohol Use DisorderCondition

Semaglutide, PlaceboTreatment

United States19 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-08-12 · NCT07218354See eligibility →

Recruiting nowPhase 3

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Obesity, OverweightCondition

Aleniglipron, PlaceboTreatment

United States71 locations

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsSponsor

Updated 2026-08-10 · NCT07654361See eligibility →

Recruiting nowPhase 2

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Breast Atypical Hyperplasia, Breast CarcinomaCondition

Biospecimen Collection, MammographyTreatment

United States3 locations

National Cancer Institute (NCI)Sponsor

Updated 2026-08-04 · NCT06195306See eligibility →

Recruiting nowNot applicable

Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance

ObesityCondition

phenotypingTreatment

United States1 locations

University of MichiganSponsor

Updated 2026-07-13 · NCT02043457See eligibility →

Recruiting nowNot applicable

Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents

Type 2 Diabetes, Insulin ResistanceCondition

Intervention not listedTreatment

United States1 locations

University of MichiganSponsor

Updated 2026-07-13 · NCT06007404See eligibility →

Recruiting nowNot applicable

The Bottle Optimization Testing Tiny Little Eaters Study

Childhood ObesityCondition

FeedingTreatment

United States1 locations

University of MichiganSponsor

Updated 2026-07-01 · NCT07665983See eligibility →

Recruiting nowNot applicable

Michigan Weight Navigation Program (MiWeigh) Study

ObesityCondition

MiWeigh, Enhanced Usual Care (EUC)Treatment

United States1 locations

University of MichiganSponsor

Updated 2026-06-12 · NCT07465341See eligibility →

Recruiting nowNot applicable

Exercise Effects on Adipose Tissue Structure and Function

Obesity, Metabolic SyndromeCondition

Exercise, No exerciseTreatment

United States1 locations

University of MichiganSponsor

Updated 2026-06-04 · NCT04812314See eligibility →

Recruiting nowNot applicable

Metabolic Adaptations to Weight Loss With and Without Exercise

Obesity, Metabolic DiseaseCondition

MICT Exercise, No Exercise (Control)Treatment

United States1 locations

University of MichiganSponsor

Updated 2026-04-14 · NCT05806801See eligibility →

Recruiting nowPhase 4

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Type2Diabetes, ASCVDCondition

SGLT2 inhibitor, GLP-1 receptor agonistTreatment

United States36 locations

Brigham and Women's HospitalSponsor

Updated 2026-04-13 · NCT05390892See eligibility →

Recruiting nowNot applicable

Families in Balance: Enhancing Household Routines and Reducing Early Childhood Obesity Among Families With Low-income

Health BehaviorCondition

Online program, Control ConditionTreatment

United States1 locations

University of MichiganSponsor

Updated 2026-04-06 · NCT06795490See eligibility →

Recruiting nowPhase 2

Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

Lipodystrophy, PartialCondition

Tirzepatide, Usual care medicationsTreatment

United States1 locations

University of MichiganSponsor

Updated 2025-09-09 · NCT07091734See eligibility →

Recruiting nowNot applicable

RESET System Pivotal Trial (Rev F)

Diabetes type2, ObesityCondition

RESET Liner, ShamTreatment

United States7 locations

Morphic Medical Inc.Sponsor

Updated 2024-07-18 · NCT04101669See eligibility →

Invitation onlyNot applicable

A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

Pregnancy, ObesityCondition

No InterventionTreatment

United States2 locations

Novo Nordisk A/SSponsor

Updated 2026-07-21 · NCT05503927See eligibility →

Invitation onlyEarly Phase 1

Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

Longevity, Quality of LifeCondition

GLP-1, PlaceboTreatment

United States1 locations

AgelessRxSponsor

Updated 2025-07-30 · NCT07092605See eligibility →

Active, not recruitingNot applicable

Guys/Girls Opt for Activities for Life Trial (GOAL) to Increase Young Adolescents' Physical Activity and Healthy Eating

Obesity, AdolescentCondition

Guys/Girls Opt for Activities for Life (GOAL)Treatment

United States2 locations

Michigan State UniversitySponsor

Updated 2026-06-22 · NCT04213014See eligibility →

Active, not recruitingNot applicable

Mother-Baby Study - Observational

Obesity, Childhood, ObesityCondition

Bonding-Evoked Oxytocin, Distress Relieving Effects of SucroseTreatment

United States1 locations

University of MichiganSponsor

Updated 2026-05-15 · NCT06039878See eligibility →

Active, not recruitingNot applicable

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Obesity, Weight Change TrajectoryCondition

Revita Duodenal Mucosal Resurfacing (DMR), ShamTreatment

United States32 locations

Fractyl Health Inc.Sponsor

Updated 2026-03-03 · NCT06484114See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Ann Arbor, United States

Current studies

Related cities